The change of name was because they are no longer focused on gold. New directors, new direction which is the way to go imo. This resource will be huge. Assay results are out of their hands along with many others. If the share price goes sub 1 again it will be a sure buy but we all know that is not going to happen.
Hopefully not long for those results.
Still an excellent buy imo at these low levels.
